-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2025.
- Lexaria Bioscience Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending August 31, 2025 was 18M shares, a 45.3% increase year-over-year.
- Lexaria Bioscience Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 18M shares, a 45.3% increase from 2024.
- Lexaria Bioscience Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 12.4M shares, a 87.2% increase from 2023.
- Lexaria Bioscience Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.61M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)